Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Gain insights into the cash back credit card payout process to understand how and when you’ll receive your rewards.
11,899 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
The U.S. shipbuilding industry is looming a 250,000-worker gap over the next decade, even as the Trump administration...
XRP trades in a narrow range as three big headwinds keep gains at bay. Analysts flag Bitcoin correlation, whale selli...
Investors are recalibrating after airports report faster screening and shorter lines, sparking a mixed revaluation of...
A nationwide poll reveals broad demand for online safeguards for children, paired with deep mistrust of current laws ...
Silicon valley's tech right is steering AI and crypto bets toward policy-friendly outcomes. Critics warn the approach...
Gas prices break above $4.50 per gallon nationwide as Middle East tensions surge, squeezing wallets ahead of peak dri...
Geopolitical tensions push yields higher, nudging mortgage rates tick higher and complicating spring homebuying for m...
The U.S. debt held by the public has eclipsed nominal GDP for the first time since World War II, a milestone that cou...
The March 2026 PCE data show the fed's favored inflation gauge staying elevated, signaling limited relief for househo...
A Yale Budget Lab study examines whether AI could solve america’s trillion debt problem, but warns the outcome hinges...
Multicoin Capital disclosed a substantial Zcash position, triggering a double-digit rally in ZEC. The move underscore...